Our Los Angeles attorneys help clients build city infrastructure, develop pharmaceuticals and medical devices, advance technology and improve health care.
Given LA's position as a thriving business center, our attorneys there practice domestically and abroad on a range of finance, corporate, fashion, entertainment and transactional matters.
Our clients are public agencies, cultural institutions and renowned educational institutions creating innovations that will drive society far into the future. They include the City and County of Los Angeles, Cedars-Sinai Medical Center, The Metropolitan Water District of Southern California, the University of Southern California, the State of California, the J. Paul Getty Museum, the Natural History Museum of Los Angeles County, Children’s Hospital of Los Angeles and Caltech.
We are active participants in advancing charitable causes of the community. As an example, the Los Angeles office handles pro bono cases for Kids in Need of Defense (KIND), an initiative that helps unaccompanied children navigate the U.S. immigration process. In addition, we are active supporters of the It Gets Better Project, which inspires hope for young people facing harassment.
- Novelty Textile Wins Major Case Over Fabric Design Copyright
California Apparel News | November 26, 2014
Los Angeles IP Counseling & Transactions partner Staci Jennifer Riordan provides commentary in this article on fashion copyright infringement.
Daily Journal | November 20, 2014
Los Angeles Health Care partner Jill Gordon and associate Daniel Eliav and Los Angeles Private Equity & Investment Funds partner Matt Grazier and associate Stephen Reil’s representation of Apollo Medical Holdings is noted in this coverage of Apollo’s launch of a new subsidiary—Apollo Palliative Services, a source for hospice, palliative and home health services.
- Don't Worry About Stem Cell Patents… Yet
Daily Journal | November 18, 2014
Los Angeles office managing partner and IP Counseling & Transactions attorney Seth Levy and Los Angeles IP Counseling & Transactions patent agent Stephen Chen authored this column discussing a recently filed U.S. Supreme Court petition in the ongoing saga about the patentability of stem cells.